UFP Technologies Inc (UFPT) is a publicly traded Healthcare sector company. As of May 21, 2026, UFPT trades at $223.83 with a market cap of $1.68B and a P/E ratio of 24.91. UFPT moved +1.74% today. Year to date, UFPT is -5.30%; over the trailing twelve months it is -6.09%. Its 52-week range spans $173.86 to $354.22. Analyst consensus is buy with an average price target of $289.00. Rallies surfaces UFPT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
UFP Technologies’ Medical Sales Surge 23.2% to $555.3m, Non-Medical Falls 11.5%: UFP Technologies grew revenue from $186m in 2020 to $602.8m in 2025, driven by a 23.2% medical segment increase to $555.3m and seven strategic acquisitions. Q1 2026 medical sales rose 5.9% to $143.4m, making up 93% of $154.2m total revenue though organic sales and operating income held flat.
| Metric | Value |
|---|---|
| Price | $223.83 |
| Market Cap | $1.68B |
| P/E Ratio | 24.91 |
| EPS | $8.90 |
| Dividend Yield | 0.00% |
| 52-Week High | $354.22 |
| 52-Week Low | $173.86 |
| Volume | 11 |
| Avg Volume | 0 |
| Revenue (TTM) | $608.85M |
| Net Income | $68.62M |
| Gross Margin | 28.35% |
2 analysts cover UFPT: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $289.00.